# Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes

> **NCT01192659** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16492 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01192659
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 16492 (ACTUAL)
- **Last updated:** 2016-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01192659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01192659, "Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01192659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*